CoChat
Sign Up
Cited by 17

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Effect of CSF1R inhibitor on glial cells population and remyelination in the cuprizone model

Tahmasebi, Fatemeh, Barati, Shirin, Kashani, Iraj Ragerdi·2021·Neuropeptides
DOI 10.1016/j.npep.2021.102179
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.npep.2021.102179

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Figures

Page 14/21
Page 14/21CC-BY · From the PDF
Figure 2
Figure 2 CC-BY · From the PDF
Figure 3
Figure 3 CC-BY · From the PDF
Figure 4
Figure 4 CC-BY · From the PDF
Figure 5
Figure 5 CC-BY · From the PDF
Figure 6
Figure 6 CC-BY · From the PDF
Image 7
CC-BY · From the PDF
Figure 7
Figure 7 CC-BY · From the PDF
Figure 8
Figure 8 CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 35

  1. Airas, 2018, Evaluation of microglial activation in multiple sclerosis patients using positron emission tomography, Front. Neurol., 9, 181, 10.3389/fneur.2018.00181 · DOI
  2. Bizzozero, 2005, Elevated protein carbonylation in the brain white matter and gray matter of patients with multiple sclerosis, J. Neurosci. Res., 81, 687, 10.1002/jnr.20587 · DOI
  3. Bjartmar, 2000, Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients, Ann. Neurol., 48, 893, 10.1002/1531-8249(200012)48:6<893::AID-ANA10>3.0.CO;2-B · DOI
  4. Correale, 2015, The role of astrocytes in multiple sclerosis progression, Front. Neurol., 6, 180, 10.3389/fneur.2015.00180 · DOI
  5. Cruz-Martinez, 2016, Intraventricular injections of mesenchymal stem cells activate endogenous functional remyelination in a chronic demyelinating murine model, Cell Death Dis., 7, 10.1038/cddis.2016.130 · DOI
  6. Davis, 2017, Characterizing microglia activation: a spatial statistics approach to maximize information extraction, Sci. Rep., 7, 1, 10.1038/s41598-017-01747-8 · DOI
  7. Domingues, 2016, Oligodendrocyte, astrocyte, and microglia crosstalk in myelin development, damage, and repair, Frontiers in cell and developmental biology, 4, 71
  8. Dutta, 2006, Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients, Ann. Neurol., 59, 478, 10.1002/ana.20736 · DOI
  9. Elmore, 2014, CSF1 receptor signaling is necessary for microglia viability, which unmasks a cell that rapidly repopulates the microglia-depleted adult brain, Neuron, 82, 380, 10.1016/j.neuron.2014.02.040 · DOI · Paper page
  10. Gibson, 2018, Bad wrap: myelin and myelin plasticity in health and disease, Developmental neurobiology, 78, 123, 10.1002/dneu.22541 · DOI
  11. Giustini, 2018, Tenosynovial giant cell tumor: case report of a patient effectively treated with pexidartinib (PLX3397) and review of the literature, Clinical sarcoma research, 8, 14, 10.1186/s13569-018-0101-2 · DOI
  12. Goldmann, 2013, Role of microglia in CNS autoimmunity, Clin. Dev. Immunol., 2013, 10.1155/2013/208093 · DOI
  13. Haider, 2011, Oxidative damage in multiple sclerosis lesions, Brain, 134, 1914, 10.1093/brain/awr128 · DOI
  14. Jäkel, 2017, Glial cells and their function in the adult brain: a journey through the history of their ablation, Front. Cell. Neurosci., 11, 24, 10.3389/fncel.2017.00024 · DOI
  15. Kant, 2020, Activated protein C attenuates experimental autoimmune encephalomyelitis progression by enhancing vascular integrity and suppressing microglial activation, Front. Neurosci., 14, 333, 10.3389/fnins.2020.00333 · DOI
  16. Kipp, 2009, The cuprizone animal model: new insights into an old story, Acta Neuropathol., 118, 723, 10.1007/s00401-009-0591-3 · DOI · Paper page
  17. Kramann, 2016, Laquinimod prevents cuprizone-induced demyelination independent of toll-like receptor signaling, Neurology-Neuroimmunology Neuroinflammation, 3, 10.1212/NXI.0000000000000233 · DOI
  18. Kuhlmann, 2008, Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis, Brain, 131, 1749, 10.1093/brain/awn096 · DOI · Paper page
  19. Liu, 2017, Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination, Acta neuropathologica communications, 5, 1, 10.1186/s40478-017-0428-6 · DOI
  20. Monif, 2010, Microglia: proliferation and activation driven by the P2X7 receptor, Int. J. Biochem. Cell Biol., 42, 1753, 10.1016/j.biocel.2010.06.021 · DOI
  21. Nelson, 2002, Microglia in diseases of the central nervous system, Ann. Med., 34, 491, 10.1080/078538902321117698 · DOI
  22. Nimmerjahn, 2005, Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo, Science, 308, 1314, 10.1126/science.1110647 · DOI · Paper page
  23. Patel, 2009, Colony-stimulating factor-1 receptor inhibitors for the treatment of cancer and inflammatory disease, Curr. Top. Med. Chem., 9, 599, 10.2174/156802609789007327 · DOI
  24. Petiet, 2016, Gray and white matter demyelination and remyelination detected with multimodal quantitative MRI analysis at 11.7 T in a chronic mouse model of multiple sclerosis, Front. Neurosci., 10, 491, 10.3389/fnins.2016.00491 · DOI
  25. Petković, 2016, Astrocyte-targeted production of interleukin-6 reduces astroglial and microglial activation in the cuprizone demyelination model: implications for myelin clearance and oligodendrocyte maturation, Glia, 64, 2104, 10.1002/glia.23043 · DOI · Paper page
  26. Slowik, 2015, The sphingosine 1-phosphate receptor agonist FTY 720 is neuroprotective after cuprizone-induced CNS demyelination, Br. J. Pharmacol., 172, 80, 10.1111/bph.12938 · DOI · Paper page
  27. Steelman, 2012, Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication, Neurosci. Res., 72, 32, 10.1016/j.neures.2011.10.002 · DOI · Paper page
  28. Suzuki, 2004, Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia, J. Neurosci., 24, 1, 10.1523/JNEUROSCI.3792-03.2004 · DOI · Paper page
  29. Szepesi, 2018, Bidirectional microglia–neuron communication in health and disease, Front. Cell. Neurosci., 12, 10.3389/fncel.2018.00323 · DOI · Paper page
  30. Tahmasebi, 2021, The effect of microglial ablation and mesenchymal stem cell transplantation on a cuprizone-induced demyelination model, J. Cell. Physiol., 236, 3552, 10.1002/jcp.30090 · DOI · Paper page
  31. Thameem Dheen, 2007, Microglial activation and its implications in the brain diseases, Curr. Med. Chem., 14, 1189, 10.2174/092986707780597961 · DOI
  32. van Horssen, 2012, Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation, J. Neuroinflammation, 9, 156, 10.1186/1742-2094-9-156 · DOI · Paper page
  33. Wang, 2019, Targeting microglia and macrophages: a potential treatment strategy for multiple sclerosis, Front. Pharmacol., 10, 286, 10.3389/fphar.2019.00286 · DOI
  34. Wies Mancini, 2019, Microglial modulation through colony-stimulating factor-1 receptor inhibition attenuates demyelination, Glia, 67, 291, 10.1002/glia.23540 · DOI
  35. Wolswijk, 2000, Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis, Brain, 123, 105, 10.1093/brain/123.1.105 · DOI

Cited by

Sorted by citations

See all 17

Metadata

Authors
Tahmasebi, F., Barati, S., & Kashani, I. R.
Venue
Neuropeptides
Publisher
Elsevier BV
Published
2021-10
Volume
89
Pages
102179
ISSN
0143-4179
DOI
10.1016/j.npep.2021.102179
Cited by
17
References
4
Language
en
Licence
Funders
Tehran University of Medical Sciences and Health Services (95.04.3033645)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review